Shenzhen Haiwang Pharmaceutical Technology Research Institute

Shenzhen Neptunus Pharmaceutical Technology Research Institute is the primary research and development arm of the Shenzhen Neptunus Bioengineering Group. The institute focuses on the development of innovative drugs, generic medications, and health products across various therapeutic areas including oncology, cardiovascular health, and anti-infectives. It operates as a high-tech enterprise integrated within one of China's largest pharmaceutical conglomerates, leveraging extensive laboratory facilities to advance candidates from early-stage discovery through clinical development. The institute plays a critical role in maintaining the parent company's competitive edge in the Chinese domestic market through continuous product lifecycle management and new drug innovation.